Stem cell therapy is a potential treatment for spinal cord injury (SCI), and a variety of different
stem cell types have been evaluated in animal models and humans with SCI. No consensus …

A phase 1 open-label, non-randomized clinical trial was conducted to determine feasibility
and safety of autologous human Schwann cell (ahSC) transplantation accompanied by …

Chondroitinase ABC (ChABC) in combination with rehabilitation has been shown to promote
functional recovery in acute spinal cord injury. For clinical use, the optimal treatment window …

BACKGROUND: In recent years, some studies were conducted to evaluate the effects of
stem cells from different sources on patients with spinal cord injury (SCI). This study was …

Over the past three decades, multiple mechanisms limiting central nervous system
regeneration have been identified. Here, we address plasticity arising from spared systems …

Over the past 2 decades, advances in understanding the pathophysiology of spinal cord
injury (SCI) have stimulated the recent emergence of several therapeutic strategies that are …

Study design: Review by the spinal cord outcomes partnership endeavor (SCOPE), which is
a broad-based international consortium of scientists and clinical researchers representing …

Study design: Retrospective, longitudinal analysis of motor recovery data from individuals
with cervical (C4–C7) sensorimotor complete spinal cord injury (SCI) according to the …

Several experimental studies have introduced Schwann cell transplantation as a means of
recovery in animal models of spinal cord injury (SCI). The reported promising results …

The debate over the effects of the timing of surgical spinal decompression after traumatic
spinal cord injury (tSCI) has remained unresolved for over a century. The aim of the current …